Experienced in Pneumocystis Jiroveci Pneumonia

Dr. Michael S. Silverman

Hematology Oncology
5200 Ne 2nd Ave, 
Miami, FL 
Experienced in Pneumocystis Jiroveci Pneumonia
5200 Ne 2nd Ave, 
Miami, FL 
OverviewInsuranceLocationsClinical Research

Overview

Michael Silverman is a Hematologist Oncology provider in Miami, Florida. Dr. Silverman is rated as an Experienced provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Cavernous Sinus Thrombosis, Pneumocystis Jiroveci Pneumonia, and Lemierre Syndrome.

His clinical research consists of co-authoring 150 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Pneumocystis Jiroveci Pneumonia.

Specialties
Hematology Oncology
Licenses
Internal Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

5200 Ne 2nd Ave, Miami, FL 33137

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug
Study Drug: CRS3123
Study Phase: Phase 2

1 Total Publications

The NEALS primary lateral sclerosis registry.
The NEALS primary lateral sclerosis registry.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 11, 2020

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silverman's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile